首页> 外文期刊>Cancer biology & therapy >Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria.
【24h】

Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria.

机译:潘克拉斯汀和他莫昔芬对乳腺癌细胞的协同作用通过靶向线粒体来诱导细胞凋亡。

获取原文
获取原文并翻译 | 示例
       

摘要

Pancratistatin (PST), a natural compound obtained from the Hawaiian spider lily, is known to be specific and selective in inducing apoptosis in multiple cancer cell lines while sparing noncancerous cells and cell lines. Here we report the ability of PST to induce apoptosis specifically in human breast cancer cell lines MCF-7 and Hs-578-T compared to their non cancerous counterparts. In cancer cells PST caused increased levels of reactive oxygen species (ROS), decreased ATP and mitochondrial membrane permeabilization indicating the activation of the mitochondrial pathway of apoptosis. In combination with the anti-estrogen Tamoxifen, PST had a synergic effect. Both compounds caused increased production of ROS when applied to isolated mitochondria from these cancer cell lines supporting the observation that Tamoxifen might work through mechanisms distinct from the canonical estrogen receptor antagonism.
机译:潘克拉斯汀(PST)是一种从夏威夷蜘蛛百合中获得的天然化合物,已知在诱导多种癌细胞系的凋亡同时保留非癌细胞和细胞系方面具有特异性和选择性。在这里,我们报告了P​​ST能够诱导人乳腺癌细胞系MCF-7和Hs-578-T与其非癌性对应物特异性凋亡的能力。在癌细胞中,PST引起活性氧(ROS)水平升高,ATP和线粒体膜通透性降低,表明细胞凋亡的线粒体途径被激活。 PST与抗雌激素他莫昔芬联合使用具有协同作用。当将这两种化合物应用于这些癌细胞系中分离的线粒体时,都会引起ROS的产生增加,这支持了他莫昔芬可能通过不同于经典雌激素受体拮抗作用的机制起作用的观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号